AcelRx Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for th…

Drug Manufacturers - Specialty & Generic
US, Hayward [HQ]

Risk Factors

By Management
Not Available

    No Risk Factor available yet. You can request "Risk Factors" through an email.

End of ACRX's Analysis
CIK: - CUSIP: 00444T100 LEI: - UEI: -
Secondary Listings
ACRX has no secondary listings inside our databases.